QUOTIENT SCIENCES LIMITED offer service "Inhaled Drug Development"

With a 30-year track record in developing and manufacturing inhaled drug products, this team has experience across delivery platforms including dry powder inhalers (DPIs) and inhalation solutions/suspensions. Integrated capabilities and deep nasal and pulmonary delivery expertise help clients move molecules from first-in-human studies through proof of concept and into full development, covering pre-formulation and API characterization, formulation and process development, inhaled device evaluation and selection, clinical manufacturing and supply across Phases I-III, and clinical pharmacology assessments, supported by a wide range of processing and analytical equipment including spray drying, micronization, and blending and encapsulation.